Karolinska Development AB (publ), KDEV

The presentation will also be webcast and can be accessed from the following web address: http: / / edge.media-server.com / m / p / bzmwoimv Host: Jim Van heusden, CEO.

24.02.2017 - 13:16:49

UPDATE: Karolinska Development - Q4 and 2016 Year-End Report - clarifies publication time and new time for conference call and webcast

STOCKHOLM - FEBRUARY 24, 2017. Karolinska Development AB (Nasdaq Stockholm: KDEV) will publish its Q4 and 2016 Year-End Report after market close on February 28, 2017. The company will host a conference call and an online presentation on 1 March at 8.00am CET. Please dial in at one of the following numbers a few minutes before the start of the conference call: * From Sweden: 46 (0) 8 505 564 74 * From the US: 1 855 753 22 30 * From the UK: 44 (0) 20 336 453 74

The presentation will also be webcast and can be accessed from the following web address: http://edge.media-server.com/m/p/bzmwoimv Host: Jim Van heusden, CEO.

For further information, please contact: Jim Van heusden, CEO, Karolinska Development AB Phone: 46 72 858 32 09, e-mail: jim.van.heusden@karolinskadevelopment.com

Christian Tange, CFO, Karolinska Development AB Phone: 46 73 712 14 30, e-mail: christian.tange@karolinskadevelopment.com

David Dible/Mark Swallow/Pip Batty, Citigate Dewe Rogerson Phone: 44 20 7638 9571; e-mail: KDev@citigatedr.co.uk


About Karolinska Development AB Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients' lives and provide an attractive return on investment.

Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.

Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.

The Company is led by a team including investment professionals with strong venture capital backgrounds, experienced company builders and entrepreneurs, with access to a strong global network.

For more information, please visit www.karolinskadevelopment.com

Karolinska development Q4 2016 invitation correction (ENG): http://hugin.info/143071/R/2081840/784350.pdf

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Karolinska Development AB (publ) via GlobeNewswire

@ hugingroup.com

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!